NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/03/2024
Back to search
Official data from USPTO
ASK US PHARMACIST.COM ONE PATIENT AT A TIME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
09/03/2024
Trademark type
Combined
Nice classes
35, 44
Filing date
12/28/2022
Registration date
09/03/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/03/2024
Last transaction
09/03/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
07/25/2022
First use in commerce
07/25/2022
Drawing code
3
Owner type
16
Owner location
Ellicott City, MD
Examiner
GILBERT, HANNAH
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a design of a speech bubble with a cross inside the bubble, below which is the stylized wording "ASK US PHARMACIST" and below the last three letters of "PHARMACIST" is ".COM", below all of which is the stylized wording "ONE PATIENT AT A TIME".
Holders and representatives
Holders
US Drug Information Service, LLC
Representatives
D. Benson Tesdahl POWERS, PYLES, SUTTER & VERVILLE, P.C.
Technical classification
Nice Classes
Class 35Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Providing an on-line website featuring consumer information and advice for consumers in the choice of products in the field of pharmaceutical products
Class 44
Providing on-line computer servicesan on-line website featuring news and information in the field of medicine and pharmaceutical products advice; providing information for consumers regarding the field of medicine and relating to diagnosticprophylactic and therapeutic properties of pharmaceutical products
Publications
History of USPTO decisions and trademark events.
30 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/03/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/09/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/06/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/03/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/03/2024
IUAF
USE AMENDMENT FILED
03/13/2024
EISU
TEAS STATEMENT OF USE RECEIVED
03/13/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/12/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/16/2024
PUBO
PUBLISHED FOR OPPOSITION
01/16/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/27/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/11/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/10/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/10/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/08/2023
GNRT
NON-FINAL ACTION E-MAILED
12/08/2023
CNRT
NON-FINAL ACTION WRITTEN
12/08/2023
LOPR
LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
12/08/2023
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
10/24/2023
ALIE
ASSIGNED TO LIE
10/23/2023
DOCK
ASSIGNED TO EXAMINER
09/25/2023
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
05/23/2023
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
05/17/2023
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
05/17/2023
LOPT
LETTER OF PROTEST EVIDENCE FORWARDED
04/04/2023
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/24/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/23/2023
NWAP
NEW APPLICATION ENTERED
12/31/2022
Continuous trademark protection
Get notified about every new filing that threatens ASK US PHARMACIST.COM ONE PATIENT AT A TIME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.